Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS5855123B2 - RBA Noseizouhou - Google Patents
[go: Go Back, main page]

JPS5855123B2 - RBA Noseizouhou - Google Patents

RBA Noseizouhou

Info

Publication number
JPS5855123B2
JPS5855123B2 JP48131479A JP13147973A JPS5855123B2 JP S5855123 B2 JPS5855123 B2 JP S5855123B2 JP 48131479 A JP48131479 A JP 48131479A JP 13147973 A JP13147973 A JP 13147973A JP S5855123 B2 JPS5855123 B2 JP S5855123B2
Authority
JP
Japan
Prior art keywords
rba
solvent
noseizouhou
rice bran
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP48131479A
Other languages
Japanese (ja)
Other versions
JPS5077518A (en
Inventor
幸夫 杉野
昌夫 津田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP48131479A priority Critical patent/JPS5855123B2/en
Publication of JPS5077518A publication Critical patent/JPS5077518A/ja
Publication of JPS5855123B2 publication Critical patent/JPS5855123B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】 本発明は新規生理活性物質RBAの製造法に関する。[Detailed description of the invention] The present invention relates to a method for producing a novel physiologically active substance RBA.

本発明者らは米ぬか中に特殊な生理活性を有する物質が
存在することを見出し、該物質の単離について種々検討
の結果、該物質を可溶な溶媒で抽出採取することに成功
し、該物質をRBAと命名した。
The present inventors discovered that a substance with special physiological activity exists in rice bran, and as a result of various studies on the isolation of this substance, they succeeded in extracting and collecting the substance with a soluble solvent. The substance was named RBA.

本発明は上記の新知見にもとづいて完成されたもので、
米ぬかを溶媒で抽出してRBAを採取することを特徴と
するRBAの製造法である。
The present invention was completed based on the above new findings,
This method of producing RBA is characterized by extracting rice bran with a solvent to collect RBA.

本発明の方法によって得られるRBAは特定の糖鎖、特
にN−アセチルグルコサミンに親知性をもち、細胞表面
〔たとえば、赤血球表面、白血球(リンパ球も含む)表
面、遊離脂肪細胞表面、正常細胞表面、ある種のかん細
胞表面など〕の糖鎖、なかでもとくにある種のかん細胞
表面糖鎖とよく結合して、血球凝集作用、インシュリン
様作用、がん細胞凝集作用、細胞の生長促進作用などを
示し、糖尿病治療剤、がん診断剤などとして有用である
RBA obtained by the method of the present invention has an affinity for specific sugar chains, especially N-acetylglucosamine, and has a affinity for specific sugar chains, especially N-acetylglucosamine, and is suitable for cell surfaces [e.g., red blood cell surface, white blood cell (including lymphocyte) surface, free adipocyte surface, normal cell surface. It binds well to sugar chains on the surface of certain types of cells, particularly on the surface of certain types of cells, and has hemagglutinating effects, insulin-like effects, cancer cell aggregating effects, and cell growth-promoting effects. It is useful as a diabetes treatment agent, a cancer diagnostic agent, etc.

本発明の方法によって得られろRBAは植物性蛋白であ
り、次のような性状を有する。
RBA obtained by the method of the present invention is a vegetable protein and has the following properties.

(1)分子量は約13000〜17000であり、6M
−グアニジン−1M−プロピオン酸の系などで、もはや
サブユニット化しない。
(1) The molecular weight is about 13,000 to 17,000, and 6M
- In systems such as guanidine-1M-propionic acid, it is no longer subunitized.

(2)糖結合部位を2個以上有する。(2) It has two or more sugar binding sites.

(3)等重点は7〜10である。(3) Equal points are 7-10.

(4)フェノール硫酸法およびガスクロマトグラフィに
よって測定した糖含量は約02〜1.0%である。
(4) Sugar content measured by phenol-sulfuric acid method and gas chromatography is about 0.02-1.0%.

(5)6N−塩酸で110℃において、24時間加水分
解して回収したRBA構成全アミノ酸100モル当りの
各構成アミノ酸のモル数は次表の通りである。
(5) The number of moles of each constituent amino acid per 100 moles of all the amino acids constituting RBA recovered by hydrolysis with 6N-hydrochloric acid at 110°C for 24 hours is as shown in the following table.

(6) O,OO3〜0.005 m9/’mlでウ
サギ血球を凝集させる。
(6) Agglutinate rabbit blood cells with O,OO3~0.005 m9/'ml.

本発明の方法における原料物質としては米ぬかが用いら
れるが、ここにいう米ぬかとは玄米などのような米ぬか
か含有物をも含むものである。
Rice bran is used as the raw material in the method of the present invention, and rice bran herein also includes rice bran-containing substances such as brown rice.

本発明の方法は米ぬかを目的物可溶な溶媒で抽出採取す
ることによって行なわれる。
The method of the present invention is carried out by extracting and collecting rice bran with a solvent in which the target substance is soluble.

米ぬかはそのまま抽出採取操作に付してもよいし、また
所望により摩砕してもよい。
The rice bran may be subjected to the extraction and collection operation as it is, or may be ground if desired.

また抽出採取操作に付する前にあらかじめ親脂性有機溶
媒、たとえばアセトン、クロロホルムなどで脱脂すれば
より好ましい結果が得られる。
Further, more preferable results can be obtained if the sample is degreased with a lipophilic organic solvent such as acetone or chloroform before being subjected to the extraction and collection operation.

抽出採取のための溶媒としてはRBAを溶出する能力が
あればいずれでもよく、たとえば水性溶媒(たとえば、
食塩水溶液、リン酸緩衝液など)、極性有機溶媒(たと
えばメタノール、エタノール、グロパノールなど)、含
水極性有機溶媒(たとえばアルコール溶液、希酢酸など
)があげられる。
Any solvent may be used for extraction and collection as long as it has the ability to elute RBA, such as an aqueous solvent (e.g.
Examples include saline solution, phosphate buffer, etc.), polar organic solvents (eg, methanol, ethanol, gropanol, etc.), and water-containing polar organic solvents (eg, alcohol solution, dilute acetic acid, etc.).

該抽出溶媒はさらに界面活性剤(たとえばデオキシコー
ル酸ナトリウム、ドデシル硫酸ナトリウムなど)などの
溶解助剤を含んでいてもよい。
The extraction solvent may further contain a solubilizing agent such as a surfactant (eg, sodium deoxycholate, sodium dodecyl sulfate, etc.).

また溶媒による抽出採取後、さらに必要に応じて自体公
知の方法、たとえばイオン交換セルロース法、ゲル沢過
法、親和性クロマトグラフィ法などによって精製処理を
行なってもよく、特に糖蛋白の一種であるオボムコイド
を化学的に不活性化したカラム支持体を使用する親和性
クロマトグラフィによる精製方法が有利に使用される。
Further, after extraction and collection with a solvent, purification treatment may be performed as necessary by a method known per se, such as an ion-exchange cellulose method, a gel filtration method, an affinity chromatography method, etc. In particular, ovomucoid, which is a type of glycoprotein, A method of purification by affinity chromatography using a chemically inactivated column support is advantageously used.

さらにまた、前記精製処理に付する前に抽出採取液をあ
らかじめ、たとえば硫酸アンモニウムなどで塩析してR
BAを沈澱として分取し、これを少量の前出の溶媒に溶
解してから前記精製処理に付するのが有利である。
Furthermore, the extracted liquid may be salted out with ammonium sulfate or the like before being subjected to the purification treatment.
It is advantageous to separate the BA as a precipitate, dissolve it in a small amount of the aforementioned solvent, and then subject it to the purification treatment.

実施例 あらかじめ、アセトンでよく脱脂して乾燥させておいた
市販米ぬか1501に、0.9%食塩水1.5 l(p
H5,0)を加えて、4℃で一夜攪拌する。
Example 1.5 liters of 0.9% saline solution (p
Add H5,0) and stir at 4°C overnight.

沢過および遠心分離で残渣を除いたのち、上清に硫安を
60%飽和となるように加えろ。
After removing the residue by filtration and centrifugation, add ammonium sulfate to the supernatant to 60% saturation.

数時間放置後、遠心分離して沈澱を集めろ。After standing for several hours, centrifuge and collect the precipitate.

沈澱を0.1Mの酢酸緩衝液(pH5,0)にとかし、
この上清をあらかじめ同じ緩衝液で充分緩衝状態にして
おいたオボムコイド・セファローズ カラム(10ml
)のカラムにマウントしたのち、同じ緩衝液で洗浄する
Dissolve the precipitate in 0.1M acetate buffer (pH 5,0),
This supernatant was placed on an Ovomucoid Sepharose column (10ml) that had been sufficiently buffered with the same buffer solution.
) and then washed with the same buffer.

吸着しない蛋白を充分洗い除いたのちに、0.1 M酢
酸で、吸着したRBAを溶離させ、さらにCM−セルロ
ーズ(pH8,0)のクロマトグラフィーで、少量の不
活性蛋白を除去して55■のRBAが得られた。
After thoroughly washing away unadsorbed proteins, the adsorbed RBA was eluted with 0.1 M acetic acid, and a small amount of inactive protein was removed using CM-cellulose (pH 8,0) chromatography. of RBA was obtained.

かくして得られたRBAはディスク電気泳動(7,5%
ポリアクリルアミドケル、pH4,0で60分(577
1,A)泳動、RBAをコマジー・ブルー染色したもの
)で均一なバンドを示した。
The RBA thus obtained was subjected to disk electrophoresis (7.5%
Polyacrylamide gel, pH 4.0 for 60 minutes (577
1.A) Electrophoresis, RBA stained with Comassie Blue) showed uniform bands.

(註) オボムコイド・セファローズの調を法;卵白を
、ジャーナル・オブ・バイオロジカル・ケミストリー、
第171巻、第565〜581(1947年)に記載の
方法に準じ、酸性アセトンで分画してオボムコイドを得
、該オボムコイドをメンズ・イン・エンザイモロジー、
第22巻、第345〜378頁(1972年)に記載の
方法に準じ、シアノジエンブロマイドで活性化したセフ
ァローズに結合させた。
(Note) Preparation of ovomucoid sepharose; albumen, Journal of Biological Chemistry,
According to the method described in Vol. 171, No. 565-581 (1947), ovomucoid was obtained by fractionation with acidic acetone, and the ovomucoid was purified by Men's in Enzymology.
It was bound to Sepharose activated with cyanodiene bromide according to the method described in Vol. 22, pp. 345-378 (1972).

Claims (1)

【特許請求の範囲】[Claims] 1 米ぬかを溶媒で抽出してRBAを採取することを特
徴とするRBAの製造法。
1. A method for producing RBA, which comprises extracting rice bran with a solvent to collect RBA.
JP48131479A 1973-11-22 1973-11-22 RBA Noseizouhou Expired JPS5855123B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP48131479A JPS5855123B2 (en) 1973-11-22 1973-11-22 RBA Noseizouhou

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP48131479A JPS5855123B2 (en) 1973-11-22 1973-11-22 RBA Noseizouhou

Publications (2)

Publication Number Publication Date
JPS5077518A JPS5077518A (en) 1975-06-24
JPS5855123B2 true JPS5855123B2 (en) 1983-12-08

Family

ID=15058924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48131479A Expired JPS5855123B2 (en) 1973-11-22 1973-11-22 RBA Noseizouhou

Country Status (1)

Country Link
JP (1) JPS5855123B2 (en)

Also Published As

Publication number Publication date
JPS5077518A (en) 1975-06-24

Similar Documents

Publication Publication Date Title
JP3731150B2 (en) Purification method of cartilage-type proteoglycan
WO1997032896A1 (en) Antitumor substance extracted from hen-of-the-woods
JP3071669B2 (en) Antiallergic substance, method for producing the same, antiallergic agent and functional food
CN108299547B (en) A kind of method for preparing glycoprotein from sclerotia of tiger milk mushroom
CN105924498B (en) Preparation method of mung bean protein with blood fat reducing effect
JP2001172296A (en) Purification method of cartilage type proteoglycan
CN114044807B (en) A mussel hypolipidemic oligopeptide for treating hyperlipidemia
CN110105430B (en) Ginkgo fruit protein peptide with angiotensin-converting enzyme inhibitory activity and preparation method thereof
JP4233029B2 (en) Maitake extract, glycoprotein, and production method thereof
JPS5855123B2 (en) RBA Noseizouhou
CN110183516B (en) A kind of preparation method of blood pressure lowering ginkgo fruit protein peptide
JPH0825891B2 (en) Lipase inhibitor derived from defatted rice germ
CN110194786B (en) A kind of ginkgo fruit protein peptide with ACE inhibitory activity and its preparation method
CN117402215B (en) Corn peptides that inhibit α-glucosidase activity and preparation methods and applications thereof
CA1243014A (en) Tissue protein pp in21 xx, a process for obtaining it and its use
CN118909097A (en) Preparation method of sea cucumber elastin peptide
JP2838863B2 (en) Hypoglycemic inhibitor
JP2838862B2 (en) Hypoglycemic agent
CN116082491A (en) Hypoglycemic oligopeptide of tap fish bone collagen
Campo Studies on extractable and resistant proteoglycans from metaphyseal and cortical bone and cartilage
JP4480204B2 (en) Anti-tumor fraction of Kawariharatake
JP2918564B2 (en) Immune enhancer
JP2701005B2 (en) Desensitizer
CN115611994B (en) Withania somnifera polysaccharide, and preparation method and application thereof in blood glucose reduction
JP3334016B2 (en) Anti-diabetic active substance, anti-diabetic complication active substance and method for producing the same